Search Results - "Lakes, J"

MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer by Boschheidgen, M, Schimmöller, L, Radtke, J P, Kastl, R, Jannusch, K, Lakes, J, Drewes, L R, Radke, K L, Esposito, I, Albers, P, Antoch, G, Ullrich, T, Al-Monajjed, R

“…This study aims to analyse multiparametric MRI (mpMRI) characteristics of patients diagnosed with ISUP grade group (GG) 1 prostate cancer (PC) on initial…”
Get full text

MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer by Quentin, M., Boschheidgen, M., Radtke, J.P., Spohn, F., Ullrich, T., Drewes, L., Valentin, B., Lakes, J., Al-Monajjed, Arsov, C., Esposito, I., Albers, P., Antoch, G., Schimmöller, L.

“…•Systematic and targeted MRI/US fusion-guided biopsy can miss csPC.•MRI in-bore biopsy detected csPC in 47% after inconclusive MRI/US fusion-guided biopsy.•MRI…”
Get full text

PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications by Morawitz, J., Kirchner, J., Lakes, J., Bruckmann, N.M., Mamlins, E., Hiester, A., Aissa, J., Loberg, C., Schimmöller, L., Arsov, C., Antke, C., Albers, P., Antoch, G., Sawicki, L.M.

“…•PSMA PET/CT is superior to CT on a per-patient and per-lesion basis in biochemically recurrent prostate cancer patients.•PSMA PET/CT enables the detection of…”
Get full text

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer by Valentin, B., Schimmöller, L., Ullrich, T., Klingebiel, M., Demetrescu, D., Sawicki, L. M., Lakes, J., Mally, D., Quentin, M., Esposito, I., Albers, P., Antoch, G., Arsov, C.

“…Objectives The aim of this study was to investigate 3 Tesla multiparametric magnetic resonance imaging (mpMRI)-based predictors for the pretherapeutic T…”
Get full text

PSA screening and molecular markers by Lakes, J, Arsov, C

“…Prostate cancer (PCA) is the most common type of cancer in men. The significant increase in incidence is most likely caused by the overdiagnosis of prostate…”
Get full text

PSA-Screening und molekulare Marker by Lakes, J., Arsov, C.

“…Zusammenfassung Hintergrund Das Prostatakarzinom (PCA) ist das häufigste Karzinom des Mannes. Die zunehmende Inzidenz wird der Überdiagnostik insignifikanter…”
Get full text

A0529 - Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk) by Rabe, A.H., Lakes, J., Karger, A., Wieczorek, D., Redler, S., Al-Monajjed, R., Fehm, T., Antoch, G., Schimmöller, L., Fugmann, D., Radke, J-P., Albers, P.

Get full text

Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk) by Rabe, A.H., Lakes, J., Karger, A., Wieczorek, D., Redler, S., Al-Monajjed, R., Fehm, T., Antoch, G., Schimmöller, L., Fugmann, D., Radke, J-P., Albers, P.

Get full text

Re: Retroperitoneal Lymph Node Dissection in the Setting of Elevated Markers by Richie, Jerome P

Get full text

Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial by Meissner, V.H., Dinkel, A., Kron, M., Schiele, S., Lakes, J., Radtke, J.P., Kuczyk, M., Harke, N., Debus, J., Körber, S., Antoch, G., Schimmöller, L., Kristiansen, G., Krilaviciute, A., Seibold, P., Behrens, S., Benner, A., Arsov, C., Hadaschik, B., Becker, N., Kaaks, R., Albers, P., Gschwend, J.E., Herkommer, K.

Get full text

P239 - Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial by Meissner, V.H., Dinkel, A., Kron, M., Schiele, S., Lakes, J., Radtke, J.P., Kuczyk, M., Harke, N., Debus, J., Körber, S., Antoch, G., Schimmöller, L., Kristiansen, G., Krilaviciute, A., Seibold, P., Behrens, S., Benner, A., Arsov, C., Hadaschik, B., Becker, N., Kaaks, R., Albers, P., Gschwend, J.E., Herkommer, K.

Get full text

Digital Rectal Examination (DRE) is not useful as a solitary screening tool for prostate cancer in young men – Results from the PROBASE trial by Krilaviciute, A., Lakes, J., Radtke, J.P., Herkommer, K., Gschwend, J., Peters, I., Kuczyk, M., Koerber, S.A., Debus, J., Kristiansen, G., Schimmöller, L., Antoch, G., Makowski, M., Wacker, F., Schlemmer, H., Benner, A., Giesel, F., Siener, R., Arsov, C., Hadaschik, B., Kaaks, R., Becker, N., Albers, P.

Get full text

A0899 - Digital Rectal Examination (DRE) is not useful as a solitary screening tool for prostate cancer in young men – Results from the PROBASE trial by Krilaviciute, A., Lakes, J., Radtke, J.P., Herkommer, K., Gschwend, J., Peters, I., Kuczyk, M., Koerber, S.A., Debus, J., Kristiansen, G., Schimmöller, L., Antoch, G., Makowski, M., Wacker, F., Schlemmer, H., Benner, A., Giesel, F., Siener, R., Arsov, C., Hadaschik, B., Kaaks, R., Becker, N., Albers, P.

Get full text

Technology Retargeting For Ic Layout by Lakes, J.

Get full text

Neue Daten zur Behandlung uroonkologischer Patienten: Update Uroonkologie 2022 by Grunewald, C., Che, Y., Lakes, J., Rehlinghaus, M., Albers, P., Niegisch, G.

“…Zusammenfassung Die Behandlung uroonkologischer Erkrankungen wird zunehmend individueller und damit auch komplexer. Neue Daten zur Systemtherapie urothelialer…”
Get full text

A Pas De Deux for Choreography and Copyright by Lakes, Joi Michelle

“…In this Note, Joi Lakes argues that the 1976 Copyright Act and the rules set forth by the Copyright Office are flawed with respect to defining what constitutes…”
Get full text